Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003748596 | SCV004377409 | pathogenic | Nephronophthisis | 2023-07-06 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with INVS-related conditions. For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Gly456Glufs*54) in the INVS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in INVS are known to be pathogenic (PMID: 12872123). |
Fulgent Genetics, |
RCV005051350 | SCV005679513 | likely pathogenic | Infantile nephronophthisis | 2024-02-20 | criteria provided, single submitter | clinical testing |